Navigation Links
Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Date:8/20/2007

Company Announces Clinical Trial Plans for 4Q07/1Q08

DALLAS, Aug. 20 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc. (OTC Bulletin Board: ACCP) provided today an update on the clinical development plan of ProLindac, its novel DACH platinum polymer prodrug, and announced plans for additional human clinical trials to be initiated in late 2007/ early 2008. The ongoing clinical trial in recurrent ovarian cancer patients, designed to optimize single agent dosing through schedule diversification and dose escalation, is currently successfully completing the enrollment of its third dose cohort.

"The excellent safety profile, especially the lack of neuro- and nephrotoxicity after multiple treatment cycles, makes it possible for us now to submit an amendment to the ongoing trial which will allow us to further and aggressively explore dosing and schedule optimization in a quicker manner," stated Dr. Esteban Cvitkovic, Vice Chairman (Europe) and recently appointed Senior Director Clinical Oncology. "The recurrent ovarian patient population is an increasingly challenging indication from a regulatory standpoint. Therefore we will continue to be careful with patient eligibility in this single agent trial. We have observed a pharmacological effect at what are still sub-toxic doses which leaves room to increase the therapeutic index in this specific indication. Moreover, this will also allow us to implement combination drug trials, the other main path to obtain further clinical evidence, in a variety of indications, of the full potential for this very promising agent."

Access Pharmaceuticals is currently planning ProLindac drug combination trials to be initiated in the fourth quarter of 2007/early 2008. As has been clinically demonstrated with Eloxatin, Sanofi's marketed DACH platinum, ProLindac's antitumor effect is expected to be synergistic when utilized in combination with other reference anti-cancer agents, such as 5-fluorourcil (5FU) or
'/>"/>

SOURCE Access Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. PromegaExpress Expands Easy Access to Products with New Cabinet
2. Access and Somanta Announce Data to be Presented on Angiolix at ASCO Oncology Conference
3. Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...a, Nov. 6 With his proposed health...his sights on cutting name-brand prescription drug...l into the "Part D" coverage gap, universally know...he potential cost-cutting and feel it,s a promisin...t powerful lobbyists want a revised program that c...
(Date:11/6/2009)... Keryx Biopharmaceuticals...l on Tuesday, November 10, 2009 at 8:30 a.m. EST t... and business outlook for the remainder of 2009. ...y, will host the call. Keryx will announce its fi... to be issued prior to the call. ,, In order to...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:...ort financial results for the second quarter ended...30, 2010 on Wednesday, November 18, 2009 at 5:00 P... to discuss those results on Thursday, November 19...cond Quarter Results Conference Call Instructions ...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Prostate cancer 3A Racial disparity gap narrows men diagnosed at younger age 55570 1CMS to Focus on Stroke Care in U S Hospitals 55568 1CMS to Focus on Stroke Care in U S Hospitals 55568 2CMS to Focus on Stroke Care in U S Hospitals 55568 3MassMutual Analysis 3A Whole Life Insurance Can Help Supply Retirement Income Preserve Equity Portfolios During Bear Markets 55566 1MassMutual Analysis 3A Whole Life Insurance Can Help Supply Retirement Income Preserve Equity Portfolios During Bear Markets 55566 2MassMutual Analysis 3A Whole Life Insurance Can Help Supply Retirement Income Preserve Equity Portfolios During Bear Markets 55566 3MassMutual Analysis 3A Whole Life Insurance Can Help Supply Retirement Income Preserve Equity Portfolios During Bear Markets 55566 4MassMutual Analysis 3A Whole Life Insurance Can Help Supply Retirement Income Preserve Equity Portfolios During Bear Markets 55566 5
...c.,(Nasdaq: MEDX ) announced today that the follo...umab in melanoma, prostate cancer and other cancer... candidates for cancer,treatment, are expected to ...ing of the American Society of Clinical Oncology, ...ival, Response, Safety and Biomarker Data of Ipili...
...r mid 2008 with Phase 2 development ...RLOS, Calif., April 29 Nuvelo, Inc.,(Nasdaq: NUV...e 1,proof-of-concept trial (n=30) of NU172, demons... onset and offset of anticoagulation after,a singl...here is a significant need for anticoagulants with...
Other Medicine Technology:Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 2Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 3Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology 4Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 3Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 4
(Date:11/9/2009)... One of the top cosmetic surgeon...,” Benjamin Bassichis, MD, FACS, has recentl...f facial rejuvenation in the Facial Plastic Surger...ed Facial Plastic and Reconstructive Surgeon, Dr. ...ery and long-term facial filler treatments to achi...
(Date:11/9/2009)...EW YORK, Nov. 9 Davis Bregman ,...e house calls to residents of Manhattan in New Yor...e call by calling the office at 212-918-1629 or ...onvenience of being able to see the doctor in the ...to try this new way of seeing most patients. The ...
(Date:11/9/2009)... study finds that women treated for breast cancer ...ve dense breasts. Published in the December 15, 20...he American Cancer Society, the study,s results in...sts may benefit from additional therapies followin... indicate that women with dense breast tissue are ...
(Date:11/8/2009)...ASHINGTON, Nov. 8 Today...presentatives on passing, the Affordable Health Ca...n, and an important step in reforming America,s he...ce of Mayors Annual Meeting in Providence (RI), ma...the health care reform principles of reducing the ...
(Date:11/8/2009)...Critical legislation would strengthen Medicare, im...Nov. 8 SUMMARY: Yeste...ssed critical health care reform legislation that ...rimination by insurance companies that prices mill...e. ,, The Affordable Health Care for America ...
Breaking Medicine News(10 mins):Health News:Dallas Facial Plastic Surgeon Publishes Cutting-Edge Novel Approach To Facelift Technique 2Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:Breast density associated with increased risk of cancer recurrence 2Health News:The Nation's Mayors Commend House Passage of Health Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4
...and heart diseases were earlier considered illness...he number of young people affected// with these ai...ublished in the December edition of the Mayo Clini... illness, like high blood pressure, obesity, abnor...
...d States and Japan try to reduce occurrences of hu...officials in both countries realize// that to deve...address this problem, they must obtain accurate in... struggle with this problem because obtaining info...
...dor to boost its health tourism industry in the US...oad. // The Federation of Kerala Associations...orth America and Canada, has asked the Indian and ...S. If Kerala does it, there will be an unending st...
...cond-line HIV-AIDS drugs, Thailand has allowed, fo...ctive version of the// drug ‘Efavirenz’, which has...nc, the patent holder of the drug has opposed the ... seconded by AIDS activists and health experts. ...
...y well be the clue to how it grasps and uses langu... of its kind.// A discovery from two Georgeto...different ways of processing language. While femal...in mistakes like “I holded the bunny”. “Sex ...
...spitals in Britain, to furnish comparative charts ...nts// at hospitals in Britain. This is to understa...cancer survivors to choose which hospital would be...on. This conference was conducted by the organizat...
Other Medicine News:Health News:Young and Obese People Heading for Heart Trouble 2Health News:Obstacles to Reducing Human Injury and Death Due to Medical Error 2Health News:Obstacles to Reducing Human Injury and Death Due to Medical Error 3Health News:Obstacles to Reducing Human Injury and Death Due to Medical Error 4Health News:Gender Might Have a Say in How Your Child Speaks 2Health News:Gender Might Have a Say in How Your Child Speaks 3
Sebban Phaco Chopper, double end
Alio-Rosen Phaco PreChopper
A.W.Brown Nucleus Cracker
Ernest Nucleus Cracker
Medicine Products: